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Purpose: This study evaluated the value of preoperative cardiac screening with 
dipyridamole thallium scintigraphy and radionuclide ventriculography in vascular surgery 
patients. 
Methods: From July 1, 1989, to Dec. 31, 1991, we routinely (irrespective of the patient's 
cardiac history or symptomatology) performed ipyridamole thallium scintigraphy (DTS) 
and radionudide ventriculography (RVG) in 394 patients being considered for an elective 
vascular operation. Patients with reversible defects on DTS underwent coronary arteri- 
ography. 
Results: DTS results were normal in 146 patients (37%), showed afixed defect in 75 (19%), 
and showed a reversible defect in 173 (44%). Patients with and without a history of angina 
or myocardial infarction had identical rates of reversible defects. Normal left ventricular 
function (>50%) was noted in 76% of the patients; 17% had moderate dysfunction (35% to 
50%) and 7% had a low ejection fraction (<35%). The finding of severe coronary artery 
disease led to cardiac revascularization in 17 patients who had no prior history of cardiac 
disease and in 13 patients with a history of angina or myocardial infarction. Two deaths and 
nine major complications were associated with coronary arteriography and cardiac 
revascularization. Vascular procedures (144 aortic, 53 carotid, 146 infrainguinal) were 
ultimately performed in 343 patients, with a mortality rate of 1.7% (3.5% aortic, 0% 
carotid, and 0.7% infrainguinal bypass). The nonfatal perioperative myocardial infarction 
rate was 2.0%. We monitored all 394 patients for cardiovascular events, with a mean 
follow-up of 40 months. Patients who underwent cardiac revascularization had a 4-year 
survival rate of 75%, which was similar to those with a normal DTS. Late cardiac events 
were significantly more frequent in patients who had either a reversible DTS or RVG < 35 %. 
Conclusions: Routine cardiac screening of vascular surgery patients had similar impact on 
patients irrespective of their prior history or current symptoms suggesting coronary artery 
disease. Routine screening did not result in substantial benefit. Screening studies uch as 
DTS or RVG may be most useful as part of an overall risk versus benefit assessment in 
patients without active symptoms of coronary artery disease who have less compelling 
indications for vascular intervention (claudication, moderate-sized aortic aneurysms, or 
asymptomatic carotid disease). (J Vasc Surg 1996;23:802-9.) 
Coronary artery disease is a well-established cause 
of perioperative and late morbidity and mortality in 
vascular surgery patients.1 Coronary arteriography in 
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vascular surgery patients with and without cardiac 
symptoms has revealed that approximately 60% will 
have significant coronary artery disease. 2 Previous 
work on the appropriateness of a comprehensive 
cardiac evaluation before a vascular surgical proce- 
dure has primarily focused on perioperative morbidity 
and mortality. Some authors, citing contemporary 
series with low perioperative cardiac morbidity and 
mortality without the use of preoperative cardiac 
screening protocols, have questioned the value of 
using these expensive tests. 3a Others suggest that 
cardiac screening protocols should be reserved for 
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Table I. DTS results on the basis of cardiac history 
Positive cardiac history Negative cardiac history 
(n = 159) (n = 235) Statistical analysis* 
Normal 43 (27%) 108 (46%) p < 0.05 
Reversible defect 69 (43%) 100 (43%) NS 
Fixed defect 47 (30%) 27 (11%) p< 0.05 
NS, Not significant. 
*Z 2 Test. 
patients with a history of or symptoms suggestive of 
significant coronary artery disease, s 6 Predicting both 
perioperative risk and long-term survival may be 
helpful in determining the appropriateness of per- 
forming a vascular reconstruction  certain patients, 
such as those with small-to moderate-sized aortic 
aneurysms, claudication, or asymptomatic carotid 
disease. We evaluated the perioperative and long-term 
outcomes of a series of patients who underwent 
routine dipyridamole thallium scintigraphy and radio- 
nuclide ventriculography before a variety of vascular 
reconstructive procedures. 
PATIENTS, MATERIAL,  AND METHODS 
Between July 1, 1989, and Dec. 31, 1991, 394 
consecutive patients being considered for an elective 
vascular operation underwent routine dipyridamole 
thallium scintigraphy (DTS) and radionuclide ven- 
triculography (RVG). Patients excluded from this 
cardiac screening protocol were those who had un- 
stable angina nd those who had undergone coronary 
arteriography and/or coronary revascularization (21 
patients) in the previous 12 months. The mean age of 
the study group was 67 years (range 34 to 90 years). 
The male: female ratio was 3 : 2. Risk factors included 
diabetes mellitus in 30%, hypertension i 61%, and 
cigarette smoking in 66%. One hundred fifty-five 
patients (39%) were evaluated for an aortic recon- 
structive procedure, 168 (43%) for infrainguinal re- 
vascularization, and 71 (18%) for cerebrovascular 
revascularization. 
A patient was considered to have a history of 
coronary artery disease if the patient had angina or 
evidence of a myocardial infarction in his or her 
medical history or on an electrocardiogram. One 
hundred fifty-nine (40%) patients had a medical 
history of coronary artery disease. DTS and RVG 
studies were performed as previously described. 79 
Results of the DTS studies were classified as normal, 
having a fixed defect, or having a reversible defect. A 
defect was defined as fixed if there was an area of 
decreased thallium uptake on the initial study and if 
thallium uptake was similarly decreased on the de- 
layed study. A reversible defect was defined as an 
initially decreased thallium uptake that became nor- 
real on the delayed images. RVG results were reported 
as an estimated left and right ventricular ejection 
fraction. 
Postoperatively, patients had cardiac monitoring 
for at least 24 hours and had serial electrocardiograms 
performed and cardiac enzymes measured. Myocar- 
dial infarction was determined by a new Q wave on the 
electrocardiogram of >1 mm or the presence of a 
creatinine kinase MB fraction of >5% or greater. 
Follow-up was conducted by reviews of the current 
medical records and clinic appointments a well as 
telcphone intcrviews. Cause of death was established 
by using medical rccords, death certificates, and 
interviews with both the primary physicians and next 
of kin. Survival in 22 patients who could not be 
reached was determined through the Social Security 
office. Survival curves were performed by using the 
Kaplan-Meier method. Statistical analysis was per- 
formed with the ~2 and log-rank tests. 
RESULTS 
The DTS results revealed 151 normal studies 
(38%), 74 fixed defects (19%), and 169 reversible 
defects (43%). No serious complications occurred 
during the nuclear imaging studies. The incidence of 
DTS redistribution was not significantly different 
between patients with known coronary artery disease 
(43%) and those without clinical evidence of coronary 
artery disease (43%) (Table I). A fixed defect was more 
common in patients with known cardiac disease (30% 
vs 11%, p < 0.05, ~2). Three hundred sixty-three of 
the 394 patients (92%) also had an RVG. Twenty-four 
patients (7%) had a left ventricular ejection fraction 
< 35 %; 63 (17%) had moderate ventricular dysfunction 
(35% to 49%), and normal eft ventricular function 
(>50%) was noted in 276 patients (76%). Only 39% of 
the patients with a reversible defect and identified 
left-main or triple-vessel coronary artery disease di- 
agnosed on the basis of coronary catheterization had 
an ejection fraction <50% by radionuclide ventricu- 
lography. 
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Number of patients 
Clinical Evidence Of 
Coronary Artery 
Disease ** 
DTS Results 
Coronary 
Angiography 
Results 
N=394 
Yes 
(n=159) 
Reversible Defect Normal or 
(n=69) Fixed Defect 
(n=90) 
3-Vessel 1-2 No No 
or Left Vessel* Disease Catheterization 
Main* (n=24) (n=4) (n=20) 
(n=21) 
No 
(n=235) 
Reversible Defect Normal Fixed 
(n=100) Defect 
(n=135) 
3-Vessel 1-2 No No 
or Left Vessel* Disease Catheterization 
Main* (n=49) (n=10) (n=13) 
(n=28) 
Fig. 1. Resultsofdipyridamolethalliumscintigraphyandcoronaryangiographyinpatientswith 
and without clinical evidence of coronary artery disease. (*, Number of coronary vessels with 
>50% stenosis; **, clinical indicators include angina or evidence of myocardial infarction by 
history or on electrocardiogram.) 
Table II. 30-Day cardiac morbidity and mortality results by procedure 
Aortic (n = 144) Carotid (n = 53) Infrainguinal (n = 146) Statistical analysis* 
Mortality 5 (3.5%) 0 (0%) 1 (0.7%) NS 
Cardiac mortality 2 (1.4%) 0 (0%) 1 (0.7%) NS 
Nonfatal myocardial infarction 1 (0.7%) 1 (1.9%) 6 (4.1%) NS 
NS, Not significant. 
.)~2 Test. 
One hundred thirty-six patients (80%) with a 
reversible defect and 12 (5%) of those with a normal 
study 5 or fixed defect 7 but with cardiac symptoms 
underwent coronary arteriography. Fig. 1 shows the 
DTS and coronary angiography results grouped ac- 
cording to clinical evidence of coronary artery disease. 
In 13 of the 33 patients with a reversible defect who 
did not undergo coronary arteriography, a decision 
was made not to perform a vascular procedure on the 
basis of the results of the cardiac tests. Eight patients 
with reversible defects refused coronary artcriogra- 
phy, and 12 patients were not considered candidates 
for coronary revascularization a d were not studied 
further. Severe coronary disease (three-vessel or left- 
main disease) was identified in 49 patients (23 with a 
cardiac medical history and 26 without a cardiac 
medical history). This led to coronary revasculariza- 
tion in 30 patients (22 coronary artery bypass grafting 
procedures, 8 percutaneous transluminal coronary 
angioplasty; 13 with a cardiac medical history, and 17 
without a cardiac medical history; 12 aortic, five 
cerebrovascular, 13 infrainguinal). The preoperative 
cardiac evaluation protocol was associated with a 
mortality rate of 0.5% and a morbidity rate of 2.8%. 
One fatal complication occurred during coronary 
arteriography. A 49-year-old man with no history of 
angina but with reversible ischemia on DTS, died 
from cardiac arrest during the contrast injection into 
a 99% stenosed left main coronary artery. The other 
fatality occurred after coronary revascularization. A 
79-year-old man died from multiple-system organ 
failure after five-vessel coronary bypass grafting for 
severe three-vessel disease. There were four access ite 
complications of cardiac catheterization requiring 
surgical correction; all were handled without inci- 
dent. Five patients had major complications after 
coronary artery bypass grafting, including two sternal 
wound dehiscences, one atheroembolic renal failure, 
one reoperation for bleeding, and one case of pneu- 
monia. 
Thirty-six patients were identified as high cardiac 
risk and were consequently managed nonoperatively. 
Other patients managed nonoperatively included six 
patients randomized to the medical treatment arm of 
the Asymptomatie Carotid Atherosclerosis Study, five 
who underwent percutaneous iliac balloon angioplas- 
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Table I I I .  Late results by DTS result 
Normal (n = 151) Fixed (n = 73) Reversible (n = 140) Statistical analysis* 
Cardiac mortality 6 (4%) 7 (10%) 26 (19%) p < 0.05 
Late myocardial infarction 13 (9%) 16 (22%) 28 (20%) p < 0.05 
*Z 2 Test. 
Table IV. Late results by RVG result 
<35% (n = 23) 35% to 50% (n = 56) >50% (n = 259) Statistical analysis* 
Cardiac mortality 9 (39%) 7 (12%) i5 (6%) p < 0.05 
Late myocardial nfarction 7 (30%) 9 (16%) 30 (12%) p < 0.05 
*Z 2 Test. 
ties, and four with moderate carotid stenoses deter- 
mined to be at low risk for stroke. Ultimately, 87% of 
the patients creened by DTS underwent a vascular 
procedure (144 aortic reconstructions, 53 cerebral 
revascularizations, 146 infrainguinal bypasses). The 
overall hospital 30-day mortality rate was 1.7%, and 
the perioperative myocardial infarction rate was 3.2%. 
Table II depicts the cardiac morbidity and mortality 
by procedure. Of tile 6 postoperative deaths, 5 
occurred in patients having aortic surgery and 1 
having infrainguinal revascularization. The causes of 
the three noncardiac deaths included intraoperative 
coagulopathy, stroke, and multiple-system organ fail- 
ure. All three cardiac deaths occurred within the first 
48 hours postoperatively from myocardial infarctions. 
Two of the patients had reversible defects, and one 
had a fixed defect on preoperative DTS. One did not 
have a history of coronary artery disease; the other 
two did. Nonfatal myocardial infarction occurred in 8 
patients (5 with reversible defects on DTS, 1 with a 
fixed defect, and 2 with normal scans). Six of these 
patients had known cardiac disease, but only one had 
an ejection fraction of <35%. 
During the follow-up period, 110 late deaths 
occurred. Thirty-nine of these were cardiac in origin. 
Tables III and IV depict the late cardiac events 
stratified according to the DTS and RVG results, 
respectively. Late myocardial infarction and heart 
disease as the cause of death were significantly more 
common among patients with a reversible or fixed 
defect on DTS. Similarly, patients with an RVG 
ejection fraction <35% also had a significantly higher 
risk of a late cardiac death and/or  myocardial infarc- 
tion. The overall survival curves on the basis of DTS 
and RVG results are shown in Figs. 2 and 3. Survival 
rates between patients with fixed and reversible de- 
fects were not different. Survival of the 30 patients 
who underwent coronary revascularization was no 
different han for those with a normal DTS study. 
DISCUSSION 
This study could not determine the value of DTS 
or RVG in predicting perioperative cardiac morbidity 
or mortality because some high-risk patients under- 
went coronary artery revascularization before the 
vascular procedure or did not undergo the peripheral 
vascular procedure because of identified severe coro- 
nary artery disease. Previous work has suggested that 
an abnormal DTS predicts a perioperative cardiac 
event. I°-I3 We can only state that our  15rotocol re- 
sulted in a low incidence of perioperative cardiac 
complications. This low rate of complications was 
achieved at considerable cost, however; both financial 
and in terms of patient complications. There were two 
deaths and nine major complications that occurred as 
a result of the cardiac evaluation and treatment. 
Whether or not a greater number of complications or 
deaths would have occurred in the 66 patients who 
either underwent coronary revascularization r did 
not undergo vascular procedure is unknown. How- 
ever, it seems unlikely that the net benefit would be 
substantial. Routine cardiac screening does not ap- 
pear to be justified if the focus is solely on reducing 
perioperative morbidity and mortality. 
One potential criticism of our protocol is the use 
of coronary arteriography in all patients with redistri- 
bution on DTS. Quantitative scintigraphy may have 
allowed us to better select patients for coronary 
arteriography and thus reduced the number of pa- 
tients subjected to coronary arteriography with its 
associated complications and cost. 14'15 
Selecting patients for screening on the basis of 
clinical risk factors for coronary artery disease has 
been advocated as another way of reducing the overall 
burden of screening. Eagle et al. 5 suggested stress 
cardiac perfusion studies be performed for patients 
older than age 70 and having diabetes mellitus, 
angina, ventricular ectopy, or Q wave on an electro- 
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Fig. 2. Survival results on basis of dipyridamole thallium Scintigraphy. 
cardiogram. By using these criteria, 25% of the pa- 
tients with reversible defects and 30% of the patients 
who underwent coronary revascularization i  our 
study would not have been identified. Age 70 is close 
to the median age of most studies of patients undergo- 
ing vascular procedures, and the incidence of diabetes 
is also quite high; these criteria are therefore not very 
selective. It also seems evident that the younger rather 
than older patients would bc the best candidates for 
coronary revascularization a d have the greatest po- 
tential benefit in terms of prolonging survival by re- 
ducing late cardiac morbidity and mortality. We also 
suggest that pharmacologic stress testing makes the 
most sense in sedentary patients who may have occult 
heart disease. We would proceed irectly to coronary 
arteriography in patients with symptomatic heart dis- 
ease whom we would consider candidates for preop- 
erative coronary revascularization. 
Our screening protocol was also possibly benefi- 
cial to patients with identified coronary artery disease 
who did not undergo cardiac revascularization. The 
surgeon, anesthesiologist, and consulting physicians 
were not blinded to the results of the screening 
studies. Perioperative monitoring and pharmacologic 
management may have been influenced by the results 
and contributed to the low cardiac omplication rate. 
However, it seems hard to justify the overall costs of 
the screening studies on this basis. Given the high 
incidence of coronary artery disease in vascular pa- 
tients, it may be more efficacious to treat all patients as 
if they had serious coronary artery disease. 
Another possible benefit in screening patients is 
identifying those whose long-term survival might bc 
improved by treating coronary artery disease. A 1993 
report from the Metropolitan Insurance Companies 
stated that mortality from heart disease has decreased 
by at least 40% in women and men since 1968.16 This 
decrease is likely from improvements in managing 
heart disease rather than a reduction in the incidence 
of heart disease. The 4-year survival of our 30 patients 
who underwent coronary revascularization was sig- 
nificantly better than those with fixed or reversible 
defects who did not undergo cardiac revasculariza- 
tion. These survival statistics coincide with those of a 
study at the Cleveland Clinic demonstrating im- 
proved long-term outcome in vascular patients who 
underwent coronary rcvascularization.17 A more dif- 
ficult task is to determine if identifying patients with 
coronary artery disease who do not undergo coronary 
rcvascularization at that ime increases patient survival 
through medication and risk-factor adjustments or 
improved physician awareness of coronary artery 
disease. 
Our results, along with those of similar studies, 
indicate DTS and RVG can predict long-term patient 
survival. I8'19 If evaluating long-term survival is a key 
concern, then determining ventricular function may 
be the most useful assessment. The 4-year survival of 
the 24 patients with an ejection fraction <35% on 
RVG was only 22%. We agree with Kazmers et al.20 
that RVG is a better predictor of late mortality than an 
indicator of high operative risk. Estimating long-term 
survival may be important in patients with moderate- 
sized aortic aneurysms, non-limb-threatening lower 
extremity ischemia, and asymptomatic arotid 
stenoses. Findings indicating alow estimated survival 
may suggest nonoperative therapy as a better alterna- 
tive. On the other hand, normal cardiac screening 
studies may allow recommending operative interven- 
tion with greater confidence to patients. 
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Fig. 3. Survival results on basis of radionuclide ventriculography. 
Evaluation of our routine cardiac screening pro- 
tocol outcomes has resulted in a change in our 
approach. Cardiac screening with pharmacologic 
stress testing is no longer routinely performed, and 
the majority of our patients are not screened. We 
directly proceed to coronary arteriography in patients 
with active cardiac symptoms who are candidates for 
preoperative coronary artery revascularization. Wedo 
consider DTS in young, sedentary patients who may 
have occult heart disease and would be candidates for 
coronary revascularization. In most older patients 
with symptomatic carotid disease or l imb-threatening 
ischemia, we would proceed with the necessary vas- 
cular operation without DTS or RVG. We use screen- 
ing studies in those patients with less compell ing 
indications for intervention (asymptomatic carotid 
disease, moderate abdominal aortic aneurysms, clau- 
dication) in whom cardiac risk assessment may pro- 
vide useful information for better overall risk versus 
benefit estimation. 
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DISCUSSION 
Dr. Patrick J. O'Hara (Cleveland, Ohio). Our group 
has also had a long interest in the influence of associated 
coronary disease on outcome after vascular surgery. We have 
demonstrated that late survival is favorably influenced by 
detecting and treating severe coronary disease in selected 
vascular patients, especially nondiabetic men. At this meet- 
ing last year, we reported that late survival for octogenarians 
who had undergone myocardial revascularization before 
aneurysm repair was significantly better than for those who 
did not. We have recently had an opportunity oreview our 
own experience with noninvasive cardiac stress testing 
before vascular reconstruction, and our results are strildngly 
similar to those reported by the Iowa group today. Between 
one third and one half of the patients in both studies 
subsequently underwent coronary angiography. Likewise, 
about 1 in 10 patients in each study was found to have 
coronary artery disease severe enough to warrant myocar- 
dial revascularization. The postoperative ascular mortality 
rates are very similar. The table also shows remarkable 
similarities with respect to the influence of positive nonin- 
vasive cardiac testing on late rates of myocardial infarction as 
well as late survival rates. In both studies, the patients chose 
to have preoperative coronary intervention, had few subse- 
quent cardiac complications, and had late survival rates 
indistinguishable from those of patients with normal non- 
invasive cardiac studies. 
These observations lead to the following three ques- 
tions. It has been shown that a fixed defect is the most 
significant factor influencing the late cardiac death or 
nonfatal myocardial infarction rates, and our data for this 
group appear to support this observation. Your late survival 
for these groups appears to be the same, however. Why do 
you think this is so? Second, among our patients, about 30% 
with either normal or suboptimal noninvasive t sts had 
severe coronary disease at catheterization. Furthermore, 
more than 60% of those with normal or suboptimal nonin- 
vasive tests had clinical indications of coronary artery 
disease. In your own study, 27% of patients with normal 
stress tests had a cardiac medical history. Were you able to 
determine, by segmental nalysis, for example, which of 
your patients who were not selected for myocardial revas- 
cularization were likely to develop late cardiac events? Is a 
clinical cardiac assessment still relevant, or should all pa- 
tients just have noninvasive screening? Finally, should those 
patients with abnormal noninvasive tests who do not 
undergo preliminary myocardial revascularization have pe- 
riodic testing at late follow-up to identify new areas of 
myocardial ischemia that may be amenable to treatment? 
Dr. Michael T. Schueppert. To answer your first 
question, I think that he reason why the fixed and reversible 
defects had similar survivals is that these two groups both 
have coronary artery disease. Patients who have had an 
infarct and those who have inducible ischemia lso share 
similar comorbidities such as cardiac, pulmonary, and renal 
disease. The abnormal result identifies amore ill subset of 
patients, those with shortened survival. 
To answer your second question of who should get 
cardiac stress testing before vascular procedure, I think right 
now we are not recommending that routine stress testing be 
done; it should rather be done on an individual basis to 
determine whether or not a patient might benefit from 
coronary revascularization. For example, a 56-year-old 
gentleman who has a long history of smoking comes in with 
claudication and aortoiliac disease. This may be a patient 
who would strongly benefit from cardiac testing. You would 
consider coronary artery bypass if severe triple-vessel orleft 
main coronary artery disease was detected. On the other 
hand, if you have, for example, an 82-year-old woman who 
has a gangrenous toe and needs a peripheral bypass, one is 
not likely to perform a coronary revascularization in this 
patient before her vascular procedure. Lastly, looldng at 
what to do with patients who have an abnormal test, I think 
risk factor adjustment plays a serious role. Identifying 
coronary artery disease may alter therapy other than coro- 
nary revascularization. Our main message is that the indi- 
cation for cardiac screening should be the possibility of 
altering therapy rather than the patient's history of symp- 
toms suggesting coronary artery disease. 
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Dr. B. Timothy Baxter (Omaha, Neb.). We strongly 
support your approach of selective use of cardiac screening 
tests only in patients in which it will change the surgical 
approach. One of the groups of patients in which we use 
these tests is patients with asymptomatic carotid disease 
because the benefit of surgery in that group is small, and 
these patients need to tive 3 to 5 years to realize the benefit. 
Do you use it in this group to make decisions about surgery? 
Dr. Schueppert. Yes we do. Also, another group of 
patients that might benefit from thig ldnd of test is the 
80-year-old patient with a 5-cm abdominal aneurysm. This 
test helps in two regards: (a) if it is positive, you might be 
more likely to recommend observation rather than opera- 
tion, and (b) if it is normal, it gives you and the patient more 
confidence that his perioperative cardiac risk is low and the 
predicted long-term survival from a cardiac standpoint is
good. This suggests a better operative benefit versus risk 
profile for aneurysm repair. 
